Cognitive Remediation Intervention to Prepare for Transition of Care
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT05336201
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Adolescent Behavior
- Cognitive Impairment
- Coping Skills
- Health-Related Behavior
- Self Efficacy
- Sickle Cell Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 10 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) — BEHAVIORALManualized cognitive remediation intervention that includes 1) skills-based remediation (metacognitive training), 2) parent training, and 3) cognitive behavioral approaches. Intervention targets self-management and goal-setting skill building to promote independence in activities necessary for transition of care.
Study Details
Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents with sickle cell disease for transition of care.
Key Dates
- Start date
- Jul 1, 2022
- Status verified
- Feb 2026
- Primary completion
- Sep 30, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: C-READY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)Self-management and goal-setting cognitive remediation
- Other: Wait-List Control GroupWill receive the same C-READY intervention after a 4-week wait period
Primary Outcome Measure
Transition Readiness [ Time Frame: 4-weeks ]
Central Contacts
- Donna Murdaugh, PhD2056382189
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | Murdaugh 2056382135 |
Find similar trials in Birmingham, AL
By condition
By research site
Related Studies
- Cognitive Training Intervention and Attitudes Towards GeneticsRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyEnrolling By Invitation · Genetix Biotherapeutics Inc. · Birmingham, Alabama
- Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab StudyPHASE4 · Recruiting · Novartis Pharmaceuticals · Birmingham, Alabama
- Early Life Exposures Among Children With Sickle Cell DiseaseRecruiting · University of Alabama at Birmingham · Birmingham, Alabama